Terms ending in 2038
Every in-force patent on F. Hoffmann-La Roche AG's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US D974,372 | Portion of a Display Screen with a Graphical User Interface In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,230,559 | Solid Forms of [(1S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] Acetate In force · High confidence | Roche R&D Center (China) Ltd. | In force | High confidence | |
| US 11,313,770 | Method for Online Sampling an Aliquot from a Mobile Phase Comprising an Analyte of an Apparatus for Producing a Pharmaceutical or Chemical Product In force · High confidence | Hoffman-la Roche Inc. | In force | High confidence | |
| US D976,279 | Portion of a Display Screen with a Graphical User Interface for Gameplay Application In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US D976,946 | Portion of a Display Screen with a Graphical User Interface In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US D976,947 | Portion of a Display Screen with a Graphical User Interface In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,424,031 | Digital Biomarkers for Progressing MS In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,205,720 | Digital Qualimetric Biomarkers for Cognition and Movement Diseases or Disorders In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,059,794 | Heterocyclic Compounds Useful as Dual Atx/Ca Inhibitors In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,591,362 | Orthogonal Protecting Groups for the Preparation of Stereodefined Phosphorothioate Oligonucleotides In force · High confidence | Roche Innovation Center Copenhagen A/S | In force | High confidence | |
| 52 more term ends in 2038 · Pro | |||||
10 of 62 patents shown. Soonest term end first, then patent number.
Pro members see all 62.
7 of these are in force and held by F. Hoffmann-La Roche AG.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.